These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31295413)

  • 1. Clinical trial design for unmet clinical needs: a spotlight on sepsis.
    Vincent JL; Sakr Y
    Expert Rev Clin Pharmacol; 2019 Sep; 12(9):893-900. PubMed ID: 31295413
    [No Abstract]   [Full Text] [Related]  

  • 2. Septic shock: new pharmacotherapy options or better trial design?
    Vincent JL; Van Nuffelen M
    Expert Opin Pharmacother; 2013 Apr; 14(5):561-70. PubMed ID: 23452102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-antibiotic therapies for sepsis: an update.
    Vincent JL; Mongkolpun W
    Expert Rev Anti Infect Ther; 2019 Mar; 17(3):169-175. PubMed ID: 30747016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Audio-visual presentation of information for informed consent for participation in clinical trials.
    Ryan RE; Prictor MJ; McLaughlin KJ; Hill SJ
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003717. PubMed ID: 18254029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New strategies for clinical trials in patients with sepsis and septic shock.
    Cohen J; Guyatt G; Bernard GR; Calandra T; Cook D; Elbourne D; Marshall J; Nunn A; Opal S;
    Crit Care Med; 2001 Apr; 29(4):880-6. PubMed ID: 11373487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Important issues in the design and reporting of clinical trials in severe sepsis and acute lung injury.
    Dellinger RP; Vincent JL; Marshall J; Reinhart K
    J Crit Care; 2008 Dec; 23(4):493-9. PubMed ID: 19056012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trials for severe sepsis. Past failures, and future hopes.
    Opal SM; Cross AS
    Infect Dis Clin North Am; 1999 Jun; 13(2):285-97, vii. PubMed ID: 10340167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of clinical trials in AKI: a report from an NIDDK workshop. Trials of patients with sepsis and in selected hospital settings.
    Molitoris BA; Okusa MD; Palevsky PM; Chawla LS; Kaufman JS; Devarajan P; Toto RM; Hsu CY; Greene TH; Faubel SG; Kellum JA; Wald R; Chertow GM; Levin A; Waikar SS; Murray PT; Parikh CR; Shaw AD; Go AS; Chinchilli VM; Liu KD; Cheung AK; Weisbord SD; Mehta RL; Stokes JB; Thompson AM; Thompson BT; Westenfelder CS; Tumlin JA; Warnock DG; Shah SV; Xie Y; Duggan EG; Kimmel PL; Star RA
    Clin J Am Soc Nephrol; 2012 May; 7(5):856-60. PubMed ID: 22442184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving clinical trials in the critically ill: unique challenge--sepsis.
    Annane D
    Crit Care Med; 2009 Jan; 37(1 Suppl):S117-28. PubMed ID: 19104211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of methodological issues of clinical trials in multiple sclerosis.
    Montalban X
    J Neurol Sci; 2011 Dec; 311 Suppl 1():S35-42. PubMed ID: 22206765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The difficulties of clinical trials evaluating therapeutic agents in patients with severe sepsis.
    Hall TC; Bilku DK; Al-Leswas D; Horst C; Dennison AR
    Ir J Med Sci; 2012 Mar; 181(1):1-6. PubMed ID: 22065211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, controlled clinical trials in sepsis: has methodological quality improved over time?
    Graf J; Doig GS; Cook DJ; Vincent JL; Sibbald WJ
    Crit Care Med; 2002 Feb; 30(2):461-72. PubMed ID: 11889331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome measures for clinical research in sepsis: a report of the 2nd Cambridge Colloquium of the International Sepsis Forum.
    Marshall JC; Vincent JL; Guyatt G; Angus DC; Abraham E; Bernard G; Bombardier C; Calandra T; Jørgensen HS; Sylvester R; Boers M
    Crit Care Med; 2005 Aug; 33(8):1708-16. PubMed ID: 16096445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is it time for a paradigm shift in drug research and development in endometriosis/adenomyosis?
    Guo SW; Groothuis PG
    Hum Reprod Update; 2018 Sep; 24(5):577-598. PubMed ID: 29893860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions for patients and caregivers to improve knowledge of sickle cell disease and recognition of its related complications.
    Asnani MR; Quimby KR; Bennett NR; Francis DK
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD011175. PubMed ID: 27711980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Critical analysis of noninflammatory treatments of sepsis: lessons learned from previous trials].
    Montravers P; Lasocki S; Seguin P; Malledant Y
    Ann Fr Anesth Reanim; 2007 Apr; 26(4):363-9. PubMed ID: 17336486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial Intelligence for Clinical Trial Design.
    Harrer S; Shah P; Antony B; Hu J
    Trends Pharmacol Sci; 2019 Aug; 40(8):577-591. PubMed ID: 31326235
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.